DelveInsight
DelveInsight's primary conduit for delivering intelligent information to professionals in both the business and healthcare sectors is through its meticulously crafted analytical and strategic reports. Presently, DelveInsight boasts a diverse portfolio encompassing over 3,000 Marketed and Pipeline Reports. These reports are thoughtfully categorized based on parameters such as indication, mechanism of actions, drugs, global API manufacturers, and specialized reports focusing on pivotal areas such as Onco-Immunology, Orphan Diseases, Biologics & Biosimilars, Gene Therapy, Stem Cells Therapy, and other emerging domains. This robust platform has become the go-to resource for numerous enterprises seeking to transform and redefine their business strategies.
DelveInsight's offerings extend beyond reports to encompass Consulting Projects and Competitive Intelligence services, catering to the multifaceted needs of its clientele. Moreover, the organization is dedicated to providing tailor-made research services that align with the specific interests and requirements of its clients. DelveInsight's commitment to excellence and innovation positions it as a trusted partner in the areas of business strategy and market research.
View recent articles by this publisher on our blog:
4 Blockbuster Drugs to Watch for Non-Small Lung Cancer (NSCLC)
The Power of Digital Therapeutics in Mental Health
Anti-VEGF Therapies: Forever Market Rulers of Wet-AMD Treatment?
Additional articles from this publisher
8,751 Reports from DelveInsight
-
Smoking Cessation- Pipeline Insight, 2024
Smoking Cessation- Pipeline Insight, 2024 DelveInsight’s, “Smoking Cessation- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Smoking Cessation pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical st ... Read More
-
Polycystic Kidney Diseases - Pipeline Insight, 2024
Polycystic Kidney Diseases - Pipeline Insight, 2024 DelveInsight’s, “Polycystic Kidney Diseases - Pipeline Insight, 2024” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Polycystic Kidney Diseases pipeline landscape. It covers the pipeline drug profiles, including ... Read More
-
Alcohol Use Disorder - Pipeline Insight, 2024
Alcohol Use Disorder - Pipeline Insight, 2024 DelveInsight’s, “Alcohol Use Disorder - Pipeline Insight, 2024” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Alcohol Use Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and non ... Read More
-
Lupus Nephritis - Pipeline Insight, 2024
Lupus Nephritis - Pipeline Insight, 2024 DelveInsight’s, “Lupus Nephritis - Pipeline Insight, 2024” report provides comprehensive insights about 30+ companies and 35+ pipeline drugs in Lupus Nephritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More
-
Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024
Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024 DelveInsight’s, “Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Metastatic Triple-Negative Breast Cancer (mTNBC) pi ... Read More
-
Stargardt Disease (STGD)- Pipeline Insight, 2024
Stargardt Disease (STGD)- Pipeline Insight, 2024 DelveInsight’s, “Stargardt Disease (STGD)- Pipeline Insight, 2024” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Stargardt Disease (STGD) pipeline landscape. It covers the pipeline drug profiles, including clinic ... Read More
-
Acute Coronary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034
Acute Coronary Syndrome - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 1,028,651 diagnosed prevalent cases of NCFB in the 7MM. Of these, the US accounted for approximately 37% of the cases, EU4 and the ... Read More
-
Bronchiectasis - Market Insight, Epidemiology And Market Forecast - 2034
Bronchiectasis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Chronic Obstructive Pulmonary Disease (COPD) market was valued at USD 16,075 million in 2023 and is expected to experience consistent growth during the forecast period (2024–2034). This growth is primarily d ... Read More
-
Chronic Heart Failure - Market Insight, Epidemiology And Market Forecast - 2034
Chronic Heart Failure - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of Atherosclerotic Cardiovascular Disease (ASCVD) was highest in the US among the 7MM, accounting for approximately USD 12 billion which is further expected to rise at a CAGR of 2. ... Read More
-
Eosinophilic Esophagitis - Market Insight, Epidemiology And Market Forecast - 2034
Eosinophilic Esophagitis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The total market size in the 7MM for ITP was estimated to be nearly USD 4,100 million in 2023, which is expected to grow with a significant CAGR during the forecast period. In 2023, the US accounted for ... Read More
-
Mild Cognitive Impairment - Market Insight, Epidemiology And Market Forecast - 2034
Mild Cognitive Impairment - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Parainfluenza virus infection market is projected to witness consistent growth throughout the forecast period (2024–2034). The market size of parainfluenza virus infection in the 7MM is expected to ... Read More
-
Parkinson's Disease Market Insight, Epidemiology And Market Forecast - 2034
Parkinson's Disease Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Parkinson’s disease Psychosis (PDP) market is projected to witness consistent growth throughout the forecast period (2024–2034). The market size of PDP in the 7MM is expected to increase, driven by better ... Read More
-
Parkinson's Disease - Epidemiology Forecast - 2034
Parkinson's Disease - Epidemiology Forecast - 2034 Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 2,718 thousand diagnosed prevalent cases of Parkinson’s disease in the 7MM. Of these, the United States accounted for 45% of the cases, while Japan and Germany r ... Read More
-
Immune Thrombocytopenia Market Insights, Epidemiology, and Market Forecast - 2034
Immune Thrombocytopenia Market Insights, Epidemiology, and Market Forecast - 2034 Key Highlights Lupus nephritis is a severe, organ-threatening manifestation of systemic lupus erythematosus (SLE), developed in 40–60% of patients with SLE. Signs of lupus nephritis include hematuria (blood in the urin ... Read More
-
Acute Myocardial Infarction - Market Insights, Epidemiology and Market Forecast– 2034
Acute Myocardial Infarction - Market Insights, Epidemiology and Market Forecast– 2034 Key Highlights: In 2023, the total diagnosed prevalent cases of SHTG were around 3.6 million in the 7MM, of which the US accounted for the highest number of cases. Treatment for SHTG typically includes dietary chan ... Read More
-
Lupus Nephritis - Market Insight, Epidemiology And Market Forecast - 2034
Lupus Nephritis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to the IgA Nephropathy Foundation, IgA nephropathy is an autoimmune disease that attacks the kidneys and affects blood filtration in the kidneys' small blood vessels. IgA nephropathy occurs when an abn ... Read More
-
Severe Hypertriglyceridemia Market Insight, Epidemiology And Market Forecast - 2034
Severe Hypertriglyceridemia Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The total market size of eosinophilic esophagitis in 2023 was approximately USD 1,800 billion in the 7MM, which is expected to grow during the forecast period (2020-2034). Among EU4 and the UK, Germany ... Read More
-
Myotonic Dystrophy - Epidemiology Forecast - 2034
Myotonic Dystrophy - Epidemiology Forecast - 2034 Key Highlights DelveInsight's analysis indicates that there were nearly 54,068 diagnosed prevalent cases of myotonic dystrophy in the United States in 2023. Projections suggest that these cases will continue to rise, with anticipated growth reaching ... Read More
-
Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034
Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Down’s syndrome is a genetic condition caused by an error in cell division called ""nondisjunction,"" resulting in an individual having a full or partial extra copy of chromosome 2 ... Read More
-
Mild Cognitive Impairment - Epidemiology Forecast - 2034
Mild Cognitive Impairment - Epidemiology Forecast - 2034 Key Highlights In 2023, the total diagnosed prevalence of MCI in Parkinson’s disease was highest in Germany among the EU4 and the UK, accounting for nearly 995 thousand cases which is further expected to increase by 2034. In the US, in 2023, ~ ... Read More
-
Myotonic Dystrophy Market Insight, Epidemiology And Market Forecast - 2034
Myotonic Dystrophy Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 2,718 thousand diagnosed prevalent cases of Parkinson’s disease in the 7MM. Of these, the United States accounted for 45% of the cases, w ... Read More
-
Non-Cystic Fibrosis Bronchiectasis Market Insight, Epidemiology And Market Forecast - 2034
Non-Cystic Fibrosis Bronchiectasis Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The market size of AMI in the 7MM is estimated to be around USD 1,600 million in 2023 and is expected to increase with a significant CAGR during the forecast period. Among the 7MM countries, the ... Read More
-
Chronic Heart Failure - Epidemiology Forecast - 2034
Chronic Heart Failure - Epidemiology Forecast - 2034 Key Highlights In 2023, there were around nearly 20,364,270 diagnosed prevalent cases of CHF in the 7MM, which is expected to rise by 2034, and the US had the highest number of diagnosed prevalent cases of CHF among the 7MM. Germany had the highes ... Read More
-
Complement 3 Glomerulopathy Market Insight, Epidemiology And Market Forecast - 2034
Complement 3 Glomerulopathy Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Diamond-Blackfan anemia (DBA) is a rare genetic disorder that primarily affects the bone marrow's ability to produce red blood cells, leading to severe anemia. It is usually diagnosed in infancy or ear ... Read More
-
Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) – Market Insights, Epidemiology, and Market Forecast – 2034
Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) – Market Insights, Epidemiology, and Market Forecast – 2034 Key Highlights The total market size in the US for NETs was estimated to be nearly USD 1,530 million in 2023, which is expected to grow with a significant CAGR during the for ... Read More
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook